Jerusalem, 11 June, 2025 (TPS-IL) — Tel Aviv-based Lembas has launched publicly with a breakthrough in natural GLP-1 activation for weight management, backed by a $3.6 million oversubscribed pre-seed round led by FLORA Ventures.
The AI-powered startup discovered food-grade bioactives that stimulate GLP-1, a hormone regulating appetite and metabolism, offering a natural alternative to costly and side effect-prone GLP-1 drugs. Lembas’ first product, GLP-1 Edge is designed for easy integration into functional foods and supplements. With growing demand for accessible weight solutions, the funding will support commercialization and expansion of its AI-driven discovery platform.



